EODData

SHE, 300347: Hangzhou Tigermed Consulting

22 Oct 2026
LAST:

49.66

CHANGE:
 1.53
OPEN:
51.44
HIGH:
51.86
ASK:
0.00
VOLUME:
9.11M
CHG(%):
2.99
PREV:
51.19
LOW:
48.88
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Oct 2651.4451.8648.8849.669.11M
21 Oct 2652.1152.6850.7151.197.35M
20 Oct 2650.5052.1849.6051.807.57M
19 Oct 2649.4951.2848.0750.589.29M
16 Oct 2653.0054.4849.2850.0712.54M
15 Oct 2652.8054.1351.5452.069.52M
14 Oct 2654.1054.9253.0253.076.64M
13 Oct 2655.1355.8853.6454.329.61M
12 Oct 2655.0158.2755.0056.0811.36M
09 Oct 2655.0055.6552.8055.1811.28M

PROFILE

Name:Hangzhou Tigermed Consulting
About:Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Sector:Healthcare
Address:Shengda Science Park, Building A, Hangzhou, China, 310051
Website:https://www.tigermedgrp.com
ISIN:CNE100001KV8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:509.82 
Forward P/E:45.59 
PEG Ratio:45.59 
Price to Sales:6.62 
Price to Book:2.60 
Profit Margin:0.01 
Operating Margin:0.12 
Return on Assets:0.01 
Return on Equity:0.01 
DivYield:0.00 
Div/Share:0.30 
Revenue:7.29B 
EBITDA:1.619B 
Shares:737.9M 
Market Cap:36.644B 

TECHNICAL INDICATORS

MA5:50.662.0%
MA10:52.405.5%
MA20:54.8810.5%
MA50:53.768.3%
MA100:49.260.8%
MA200:52.736.2%
RSI14:28.03 
WPR14:-100.00 
MTM14:-7.14
ROC14:-0.13 
ATR:2.89 
Week High:54.489.7%
Week Low:48.073.3%
Month High:59.6620.1%
Month Low:48.076.2%
Year High:67.8536.6%
Year Low:35.5739.6%
Volatility:23.97 

RECENT SPLITS

Date Ratio
01 Jul 20191-1
20 May 201520-10
22 Apr 201420-10
02 May 201320-10

RECENT DIVIDENDS

Date Amount
17 Jun 2025$0.30
12 Jul 2024$0.57
07 Jul 2023$0.55
31 May 2022$0.50
01 Jun 2021$0.30
22 May 2020$0.28
01 Jul 2019$0.23
30 May 2018$0.13
19 Sep 2017$0.07
20 May 2016$0.07